Filing Details
- Accession Number:
- 0001209191-17-028456
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-04-27 17:00:25
- Reporting Period:
- 2017-04-20
- Filing Date:
- 2017-04-27
- Accepted Time:
- 2017-04-27 17:00:25
- Original Submission Date:
- 2017-04-24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190126 | R James Mcnab | 4 Maguire Road Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-04-20 | 22,541 | $2.66 | 1,057,147 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-04-21 | 45,705 | $2.58 | 1,011,442 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-04-24 | 42,076 | $2.56 | 969,366 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 300,000 | Indirect | By JR & MW McNab Operating LP |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.61 to $2.69, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.65, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.58, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Billionaire Hedge Funds
